If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMelrose Regulatory News (MRO)

Share Price Information for Melrose (MRO)

Share Price is delayed by 15 minutes
Get Live Data
502.80    4.10 (0.82%)
Bid:
503.80
Ask:
504.20
Spread: 0.40 (0.079%)
Market Cap: £6.27b
MRO Live PriceLast checked at - London Stock Exchange

Intraday Melrose Share Chart

GTF PW1100G update

12 Sep 2023 07:00

RNS Number : 0797M
Melrose Industries PLC
12 September 2023
 

 

 

 

 

12 September 2023

 

 

MELROSE INDUSTRIES PLC ("MELROSE" OR THE "COMPANY")

 

GTF PW1100G update

 

Melrose notes that RTX announced yesterday an update on their Pratt & Whitney GTF fleet arising from the previously disclosed rare condition in powder metal used to manufacture certain of their engine parts. This added further specificity, both for the market and for GTF programme partners, regarding the potential operational and financial impacts.

 

GKN Aerospace has a 4% programme share on the GTF PW1100G variant impacted by this issue. According to RTX's announcement, the full potential cash impact to Melrose spread over the period to 2026 could be in the range of c.£200 million, if it was assumed that this is all a programme cost.

 

Melrose's financial assumptions for all its RRSP programmes are conservative recognising that most of our work is done on the delivery of GKN parts which typically last the life of the engine, whilst appropriately allowing for risks to arise over the full programme duration. As a result, there is no change to our profit and balance sheet guidance, and the share buyback programme announced last week, starting in October this year, will proceed as planned whilst staying comfortably within previously stated leverage levels.

 

Melrose owns an exceptionally good Aerospace Engines business which can deliver over 30% operating margins post 2025, including contribution from a diverse portfolio of 19 RRSP engines contracts. This will be highlighted at the recently announced Engines Investor Event in October this year in Sweden, which will give further detail on the full quality of the business.

 

Simon Peckham, Chief Executive of Melrose Industries PLC, said:

 

"RTX indicated to us and the market yesterday that the GTF rare parts issue is within the scope they outlined previously and the cash impact is now assumed to be spread over a longer-term. We confirm our confidence in achieving the previous profit and balance sheet guidance and look forward to commencing our share buyback programme in October."

 

 

-ends-

 

 

 

Enquiries:

 

Investor Relations:

 

Chris Dyett

+44 (0) 7974 974 690

ir@melroseplc.net 

 

 

Montfort Communications:

 

Nick Miles

+44 (0) 20 3514 0897

+44 (0) 7739 701 634

miles@montfort.london

 

Charlotte McMullen

+44 (0) 20 3514 0897

+44 (0) 7921 881 800

mcmullen@montfort.london

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBIGDCUSBDGXB
Date   Source Headline
7th Mar 20197:00 amRNSFinal Results
6th Mar 20197:00 amRNSSundry Disposals
19th Dec 20187:00 amRNSDirector/PDMR Shareholding
13th Nov 20187:00 amRNSTrading Statement
19th Oct 20183:27 pmRNSAmended Holding(s) in Company
19th Oct 20181:46 pmRNSHolding(s) in Company
17th Oct 20184:47 pmRNSDirector/PDMR Shareholding
8th Oct 201810:30 amRNSAppointment
4th Oct 20184:19 pmRNSDirector/PDMR Shareholding
1st Oct 20187:00 amRNSAppointment of Director
6th Sep 20187:00 amRNSHalf-year Report
28th Aug 20183:55 pmRNSHolding(s) in Company
28th Aug 20182:22 pmRNSHolding(s) in Company
23rd Aug 20185:07 pmRNSHolding(s) in Company
23rd Aug 20185:06 pmRNSHolding(s) in Company
22nd Aug 20187:00 amRNSNotice of Results
21st Aug 201811:59 amRNSHolding(s) in Company
20th Aug 20186:13 pmRNSHolding(s) in Company
16th Aug 20185:41 pmRNSHolding(s) in Company
10th Aug 20184:09 pmRNSHolding(s) in Company
8th Aug 20184:02 pmRNSVoting Rights and Capital
8th Aug 20181:39 pmRNSHolding(s) in Company
31st Jul 201811:49 amRNSHolding(s) in Company
30th Jul 20189:18 amRNSHolding(s) in Company
5th Jul 20182:25 pmRNSHolding(s) in Company
4th Jul 20184:59 pmRNSHolding(s) in Company
26th Jun 20181:05 pmRNSVoting Rights and Capital
26th Jun 201810:44 amRNSDirector/PDMR Shareholding
25th Jun 20187:00 amRNSCFIUS Clearance
8th Jun 201812:00 pmRNSPDMR Notification
31st May 20182:43 pmRNSVoting Rights and Capital
30th May 20186:04 pmRNSHolding(s) in Company
30th May 201811:36 amRNSHolding(s) in Company
25th May 20184:20 pmRNSDirector/PDMR Shareholding
24th May 20183:08 pmRNSVoting Rights and Capital
22nd May 20184:39 pmRNSHolding(s) in Company
22nd May 20184:34 pmRNSHolding(s) in Company
22nd May 20184:33 pmRNSHolding(s) in Company
22nd May 20184:32 pmRNSHolding(s) in Company
21st May 201810:56 amRNSHolding(s) in Company
21st May 20188:00 amRNSDelisting of GKN & Continuation Of Offer
18th May 20183:54 pmRNSHolding(s) in Company
17th May 20182:59 pmRNSVoting rights and capital
10th May 201812:01 pmRNSResult of AGM
10th May 20187:00 amRNSAGM Trading Update
9th May 20186:14 pmRNSHolding(s) in Company
8th May 20189:18 amRNSHolding(s) in Company
3rd May 20186:11 pmRNSHolding(s) in Company
2nd May 20187:00 amRNSHolding(s) in Company
1st May 20183:47 pmRNSVoting Rights and Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.